心房細動市場：タイプ別（外科手術、非外科手術）、技術別（高周波、レーザー、凍結療法、その他）、エンドユーザー別（病院、専門診療所、その他）。世界の機会分析および産業予測、2020-2030年

Atrial Fibrillation Market By Type (Surgical, Non-Surgical), By Technology (Radiofrequency, Laser, Cryotherapy, Others), By End User (Hospitals, Specialty Clinics, Others): Global Opportunity Analysis and Industry Forecast, 2020-2030

心房細動の市場規模は2020年に18億2580万ドル、2021年から2030年にかけてCAGR6.4%を記録し、2030年には33億7070万ドルに達すると予測されています。房室細動（AFib）は、心臓の上室（心房）が速く不規則に拍動す... もっと見る

出版社	出版年月	電子版価格	ページ数	言語
Allied Market Research アライドマーケットリサーチ	2022年5月31日	US$5,398 シングルユーザーライセンスライセンス・価格情報注文方法はこちら	180	英語

サマリー

心房細動の市場規模は2020年に18億2580万ドル、2021年から2030年にかけてCAGR6.4%を記録し、2030年には33億7070万ドルに達すると予測されています。房室細動（AFib）は、心臓の上室（心房）が速く不規則に拍動する（細動する）疾患です。心房細動の結果、心臓の左心房付属器に血液がたまり、凝固することがあります。血栓が左心房付属器から脱出し、体の他の部分や臓器に移動すると、脳卒中が発生する可能性があります。心房細動は、特に心拍が極端に速い場合に、心筋梗塞のリスクを高め、胸部不快感を誘発し、さらには心臓発作を誘発し、心臓で血栓を生成して他の臓器に広がる可能性があります。
世界の心房細動市場は、高齢化社会の進展に伴い拡大傾向にあります。また、高血圧、肥満、糖尿病により、高齢者層における心房細動の発生が増加します。米国疾病対策予防センター（CDC）によると、米国における心房細動の有病率は約270万〜610万人であると推定されています。2030年には1,210万人に増加すると推定されています。このような要因から、予測期間中に心房細動治療器の需要が高まると予想されます。さらに、心房細動の手術用デバイスの技術的進歩は、心房細動市場を前進させる。しかし、高額な心房細動の治療費や高価な医療機器などの問題は、市場拡大の妨げになると予想されます。
さらに、技術の進歩は、主要なプレーヤーが医療や製薬分野で心房細動の監視やデバイスを導入することを余儀なくされます。例えば、2020年2月、ジョンソン・エンド・ジョンソンのヤンセンファーマカンパニーズは、アップル社と協業し、ハートラインモニターを導入しました。心房細動（AFib）を早期に発見することで、脳卒中のリスクを下げるなど、健康状態を改善するものである。
市場は、タイプ、技術、エンドユーザー、地域に基づいて区分されます。タイプ別では、外科的手術と非外科的手術に分けられます。技術別では、高周波、レーザー、凍結療法、その他に分類されます。エンドユーザー別では、病院、専門クリニック、その他に分類されます。地域別では、北米（米国、カナダ、メキシコ）、欧州（英国、フランス、ドイツ、イタリア、その他の欧州）、アジア太平洋（中国、日本、インド、韓国、その他のアジア太平洋）、LAMEA（中南米、中東、アフリカ）で市場分析が行われています。

競合分析
世界の心房細動市場で事業を展開している主要企業は、Abbott Laboratories、Johnson & Johnson、MicroPort Scientific Corporation、Boston Scientific Corporation、Medtronic plc、Biotronik SE & Co.KG、Philips N.V.、Siemens AG、AtriCure Inc.、CardioFocus, Inc.です。

ステークホルダーにとっての主なメリット
本レポートは、現在および新興の心房細動市場の動向とダイナミクスについて広範な分析を提供します。
心房細動市場の詳細な分析は、2021年から2030年までの主要な市場セグメントの市場推定を構築することによって行われます。
心房細動市場の広範な分析は、主要製品のポジショニングと市場フレームワーク内の上位競合企業のモニタリングを行うことによって実施されます。
すべての地域の包括的な分析は、優勢な機会を決定するために提供されます。
2021年から2030年までの世界の心房細動市場の予測分析が含まれています。
心房細動市場内の主要なプレーヤーは、このレポートでプロファイリングされ、彼らの戦略は、心房細動業界の競争の見通しを理解するのに役立ち、徹底的に分析されます。

心房細動の世界市場セグメント

# タイプ別
## 外科手術
## 非外科的

# 技術別
## 無線周波数
## レーザー
## 凍結療法
## その他

# エンドユーザー別
## ホスピタル
## スペシャルティクリニック
## その他

# 地域別
## 北米
### 米国
### カナダ
### メキシコ
## ヨーロッパ
### ドイツ
### イギリス
### フランス
### イタリア
### その他のヨーロッパ

## アジア太平洋地域
### 中国
### インド
### 日本
### 韓国
### その他のアジア太平洋地域

## LAMEA
### ラテンアメリカ
### 中近東
### アフリカ

主な事業者
アボット・ラボラトリーズ
ジョンソン・エンド・ジョンソン
マイクロポートサイエンティフィック株式会社
ボストン・サイエンティフィックコーポレーション
メドトロニック plc
ビオトロニック SE & Co.KG
フィリップスN.V.
シーメンスAG
アトリキュア社
カーディオフォーカス

ページTOPに戻る

CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: ATRIAL FIBRILLATION MARKET, BY TYPE
4.1 Overview
4.1.1 Market size and forecast
4.2 Surgical
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Non-Surgical
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
CHAPTER 5: ATRIAL FIBRILLATION MARKET, BY TECHNOLOGY
5.1 Overview
5.1.1 Market size and forecast
5.2 Radiofrequency
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Laser
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 Cryotherapy
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
5.5 Others
5.5.1 Key market trends, growth factors and opportunities
5.5.2 Market size and forecast, by region
5.5.3 Market analysis by country
CHAPTER 6: ATRIAL FIBRILLATION MARKET, BY END USER
6.1 Overview
6.1.1 Market size and forecast
6.2 Hospitals
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Specialty Clinics
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
6.4 Others
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market analysis by country
CHAPTER 7: ATRIAL FIBRILLATION MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key trends and opportunities
7.2.2 North America Market size and forecast, by Type
7.2.3 North America Market size and forecast, by Technology
7.2.4 North America Market size and forecast, by End User
7.2.5 North America Market size and forecast, by country
7.2.5.1 U.S.
7.2.5.1.1 Market size and forecast, by Type
7.2.5.1.2 Market size and forecast, by Technology
7.2.5.1.3 Market size and forecast, by End User
7.2.5.2 Canada
7.2.5.2.1 Market size and forecast, by Type
7.2.5.2.2 Market size and forecast, by Technology
7.2.5.2.3 Market size and forecast, by End User
7.2.5.3 Mexico
7.2.5.3.1 Market size and forecast, by Type
7.2.5.3.2 Market size and forecast, by Technology
7.2.5.3.3 Market size and forecast, by End User
7.3 Europe
7.3.1 Key trends and opportunities
7.3.2 Europe Market size and forecast, by Type
7.3.3 Europe Market size and forecast, by Technology
7.3.4 Europe Market size and forecast, by End User
7.3.5 Europe Market size and forecast, by country
7.3.5.1 Germany
7.3.5.1.1 Market size and forecast, by Type
7.3.5.1.2 Market size and forecast, by Technology
7.3.5.1.3 Market size and forecast, by End User
7.3.5.2 France
7.3.5.2.1 Market size and forecast, by Type
7.3.5.2.2 Market size and forecast, by Technology
7.3.5.2.3 Market size and forecast, by End User
7.3.5.3 U.K.
7.3.5.3.1 Market size and forecast, by Type
7.3.5.3.2 Market size and forecast, by Technology
7.3.5.3.3 Market size and forecast, by End User
7.3.5.4 Italy
7.3.5.4.1 Market size and forecast, by Type
7.3.5.4.2 Market size and forecast, by Technology
7.3.5.4.3 Market size and forecast, by End User
7.3.5.5 Rest of Europe
7.3.5.5.1 Market size and forecast, by Type
7.3.5.5.2 Market size and forecast, by Technology
7.3.5.5.3 Market size and forecast, by End User
7.4 Asia-Pacific
7.4.1 Key trends and opportunities
7.4.2 Asia-Pacific Market size and forecast, by Type
7.4.3 Asia-Pacific Market size and forecast, by Technology
7.4.4 Asia-Pacific Market size and forecast, by End User
7.4.5 Asia-Pacific Market size and forecast, by country
7.4.5.1 China
7.4.5.1.1 Market size and forecast, by Type
7.4.5.1.2 Market size and forecast, by Technology
7.4.5.1.3 Market size and forecast, by End User
7.4.5.2 India
7.4.5.2.1 Market size and forecast, by Type
7.4.5.2.2 Market size and forecast, by Technology
7.4.5.2.3 Market size and forecast, by End User
7.4.5.3 Japan
7.4.5.3.1 Market size and forecast, by Type
7.4.5.3.2 Market size and forecast, by Technology
7.4.5.3.3 Market size and forecast, by End User
7.4.5.4 South Korea
7.4.5.4.1 Market size and forecast, by Type
7.4.5.4.2 Market size and forecast, by Technology
7.4.5.4.3 Market size and forecast, by End User
7.4.5.5 Rest of Asia-Pacific
7.4.5.5.1 Market size and forecast, by Type
7.4.5.5.2 Market size and forecast, by Technology
7.4.5.5.3 Market size and forecast, by End User
7.5 LAMEA
7.5.1 Key trends and opportunities
7.5.2 LAMEA Market size and forecast, by Type
7.5.3 LAMEA Market size and forecast, by Technology
7.5.4 LAMEA Market size and forecast, by End User
7.5.5 LAMEA Market size and forecast, by country
7.5.5.1 Latin America
7.5.5.1.1 Market size and forecast, by Type
7.5.5.1.2 Market size and forecast, by Technology
7.5.5.1.3 Market size and forecast, by End User
7.5.5.2 Middle East
7.5.5.2.1 Market size and forecast, by Type
7.5.5.2.2 Market size and forecast, by Technology
7.5.5.2.3 Market size and forecast, by End User
7.5.5.3 Africa
7.5.5.3.1 Market size and forecast, by Type
7.5.5.3.2 Market size and forecast, by Technology
7.5.5.3.3 Market size and forecast, by End User
CHAPTER 8: COMPANY LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments
CHAPTER 9: COMPANY PROFILES
9.1 Johnson & Johnson
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Operating business segments
9.1.4 Product portfolio
9.1.5 Business performance
9.1.6 Key strategic moves and developments
9.2 MicroPort Scientific Corporation
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Operating business segments
9.2.4 Product portfolio
9.2.5 Business performance
9.2.6 Key strategic moves and developments
9.3 Boston Scientific Corporation
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Operating business segments
9.3.4 Product portfolio
9.3.5 Business performance
9.3.6 Key strategic moves and developments
9.4 st. jude medical
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Operating business segments
9.4.4 Product portfolio
9.4.5 Business performance
9.4.6 Key strategic moves and developments
9.5 Medtronic plc
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Operating business segments
9.5.4 Product portfolio
9.5.5 Business performance
9.5.6 Key strategic moves and developments
9.6 Abbott Laboratories
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Operating business segments
9.6.4 Product portfolio
9.6.5 Business performance
9.6.6 Key strategic moves and developments
9.7 Biotronik SE & Co. KG
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Operating business segments
9.7.4 Product portfolio
9.7.5 Business performance
9.7.6 Key strategic moves and developments
9.8 Koninklijke Philips N.V.
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Operating business segments
9.8.4 Product portfolio
9.8.5 Business performance
9.8.6 Key strategic moves and developments
9.9 Siemens AG
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Operating business segments
9.9.4 Product portfolio
9.9.5 Business performance
9.9.6 Key strategic moves and developments
9.10 AtriCure Inc
9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Operating business segments
9.10.4 Product portfolio
9.10.5 Business performance
9.10.6 Key strategic moves and developments

LIST OF TABLES
TABLE 1. GLOBAL ATRIAL FIBRILLATION MARKET, BY TYPE, 2020-2030,($MILLION)
TABLE 2. ATRIAL FIBRILLATION MARKET REVENUE, FOR SURGICAL, BY REGION , 2020-2030,($MILLION)
TABLE 3. ATRIAL FIBRILLATION MARKET SURGICAL BY COUNTRY, 2020-2030,($MILLION)
TABLE 4. ATRIAL FIBRILLATION MARKET REVENUE, FOR NON-SURGICAL, BY REGION , 2020-2030,($MILLION)
TABLE 5. ATRIAL FIBRILLATION MARKET NON-SURGICAL BY COUNTRY, 2020-2030,($MILLION)
TABLE 6. GLOBAL ATRIAL FIBRILLATION MARKET, BY TECHNOLOGY, 2020-2030,($MILLION)
TABLE 7. ATRIAL FIBRILLATION MARKET REVENUE, FOR RADIOFREQUENCY, BY REGION , 2020-2030,($MILLION)
TABLE 8. ATRIAL FIBRILLATION MARKET RADIOFREQUENCY BY COUNTRY, 2020-2030,($MILLION)
TABLE 9. ATRIAL FIBRILLATION MARKET REVENUE, FOR LASER, BY REGION , 2020-2030,($MILLION)
TABLE 10. ATRIAL FIBRILLATION MARKET LASER BY COUNTRY, 2020-2030,($MILLION)
TABLE 11. ATRIAL FIBRILLATION MARKET REVENUE, FOR CRYOTHERAPY, BY REGION , 2020-2030,($MILLION)
TABLE 12. ATRIAL FIBRILLATION MARKET CRYOTHERAPY BY COUNTRY, 2020-2030,($MILLION)
TABLE 13. ATRIAL FIBRILLATION MARKET REVENUE, FOR OTHERS, BY REGION , 2020-2030,($MILLION)
TABLE 14. ATRIAL FIBRILLATION MARKET OTHERS BY COUNTRY, 2020-2030,($MILLION)
TABLE 15. GLOBAL ATRIAL FIBRILLATION MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 16. ATRIAL FIBRILLATION MARKET REVENUE, FOR HOSPITALS, BY REGION , 2020-2030,($MILLION)
TABLE 17. ATRIAL FIBRILLATION MARKET HOSPITALS BY COUNTRY, 2020-2030,($MILLION)
TABLE 18. ATRIAL FIBRILLATION MARKET REVENUE, FOR SPECIALTY CLINICS, BY REGION , 2020-2030,($MILLION)
TABLE 19. ATRIAL FIBRILLATION MARKET SPECIALTY CLINICS BY COUNTRY, 2020-2030,($MILLION)
TABLE 20. ATRIAL FIBRILLATION MARKET REVENUE, FOR OTHERS, BY REGION , 2020-2030,($MILLION)
TABLE 21. ATRIAL FIBRILLATION MARKET OTHERS BY COUNTRY, 2020-2030,($MILLION)
TABLE 22. ATRIAL FIBRILLATION MARKET, BY REGION, 2020-2030,($MILLION)
TABLE 23. NORTH AMERICA ATRIAL FIBRILLATION MARKET, BY TYPE, 2020-2030,($MILLION)
TABLE 24. NORTH AMERICA ATRIAL FIBRILLATION MARKET, BY TECHNOLOGY, 2020-2030,($MILLION)
TABLE 25. NORTH AMERICA ATRIAL FIBRILLATION MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 26. NORTH AMERICA ATRIAL FIBRILLATION MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 27. U.S. ATRIAL FIBRILLATION MARKET BY TYPE 2020-2030,($MILLION)
TABLE 28. U.S. ATRIAL FIBRILLATION MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 29. U.S. ATRIAL FIBRILLATION MARKET BY END USER 2020-2030,($MILLION)
TABLE 30. CANADA ATRIAL FIBRILLATION MARKET BY TYPE 2020-2030,($MILLION)
TABLE 31. CANADA ATRIAL FIBRILLATION MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 32. CANADA ATRIAL FIBRILLATION MARKET BY END USER 2020-2030,($MILLION)
TABLE 33. MEXICO ATRIAL FIBRILLATION MARKET BY TYPE 2020-2030,($MILLION)
TABLE 34. MEXICO ATRIAL FIBRILLATION MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 35. MEXICO ATRIAL FIBRILLATION MARKET BY END USER 2020-2030,($MILLION)
TABLE 36. EUROPE ATRIAL FIBRILLATION MARKET, BY TYPE, 2020-2030,($MILLION)
TABLE 37. EUROPE ATRIAL FIBRILLATION MARKET, BY TECHNOLOGY, 2020-2030,($MILLION)
TABLE 38. EUROPE ATRIAL FIBRILLATION MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 39. EUROPE ATRIAL FIBRILLATION MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 40. GERMANY ATRIAL FIBRILLATION MARKET BY TYPE 2020-2030,($MILLION)
TABLE 41. GERMANY ATRIAL FIBRILLATION MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 42. GERMANY ATRIAL FIBRILLATION MARKET BY END USER 2020-2030,($MILLION)
TABLE 43. FRANCE ATRIAL FIBRILLATION MARKET BY TYPE 2020-2030,($MILLION)
TABLE 44. FRANCE ATRIAL FIBRILLATION MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 45. FRANCE ATRIAL FIBRILLATION MARKET BY END USER 2020-2030,($MILLION)
TABLE 46. U.K. ATRIAL FIBRILLATION MARKET BY TYPE 2020-2030,($MILLION)
TABLE 47. U.K. ATRIAL FIBRILLATION MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 48. U.K. ATRIAL FIBRILLATION MARKET BY END USER 2020-2030,($MILLION)
TABLE 49. ITALY ATRIAL FIBRILLATION MARKET BY TYPE 2020-2030,($MILLION)
TABLE 50. ITALY ATRIAL FIBRILLATION MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 51. ITALY ATRIAL FIBRILLATION MARKET BY END USER 2020-2030,($MILLION)
TABLE 52. REST OF EUROPE ATRIAL FIBRILLATION MARKET BY TYPE 2020-2030,($MILLION)
TABLE 53. REST OF EUROPE ATRIAL FIBRILLATION MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 54. REST OF EUROPE ATRIAL FIBRILLATION MARKET BY END USER 2020-2030,($MILLION)
TABLE 55. ASIA-PACIFIC ATRIAL FIBRILLATION MARKET, BY TYPE, 2020-2030,($MILLION)
TABLE 56. ASIA-PACIFIC ATRIAL FIBRILLATION MARKET, BY TECHNOLOGY, 2020-2030,($MILLION)
TABLE 57. ASIA-PACIFIC ATRIAL FIBRILLATION MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 58. ASIA-PACIFIC ATRIAL FIBRILLATION MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 59. CHINA ATRIAL FIBRILLATION MARKET BY TYPE 2020-2030,($MILLION)
TABLE 60. CHINA ATRIAL FIBRILLATION MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 61. CHINA ATRIAL FIBRILLATION MARKET BY END USER 2020-2030,($MILLION)
TABLE 62. INDIA ATRIAL FIBRILLATION MARKET BY TYPE 2020-2030,($MILLION)
TABLE 63. INDIA ATRIAL FIBRILLATION MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 64. INDIA ATRIAL FIBRILLATION MARKET BY END USER 2020-2030,($MILLION)
TABLE 65. JAPAN ATRIAL FIBRILLATION MARKET BY TYPE 2020-2030,($MILLION)
TABLE 66. JAPAN ATRIAL FIBRILLATION MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 67. JAPAN ATRIAL FIBRILLATION MARKET BY END USER 2020-2030,($MILLION)
TABLE 68. SOUTH KOREA ATRIAL FIBRILLATION MARKET BY TYPE 2020-2030,($MILLION)
TABLE 69. SOUTH KOREA ATRIAL FIBRILLATION MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 70. SOUTH KOREA ATRIAL FIBRILLATION MARKET BY END USER 2020-2030,($MILLION)
TABLE 71. REST OF ASIA-PACIFIC ATRIAL FIBRILLATION MARKET BY TYPE 2020-2030,($MILLION)
TABLE 72. REST OF ASIA-PACIFIC ATRIAL FIBRILLATION MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 73. REST OF ASIA-PACIFIC ATRIAL FIBRILLATION MARKET BY END USER 2020-2030,($MILLION)
TABLE 74. LAMEA ATRIAL FIBRILLATION MARKET, BY TYPE, 2020-2030,($MILLION)
TABLE 75. LAMEA ATRIAL FIBRILLATION MARKET, BY TECHNOLOGY, 2020-2030,($MILLION)
TABLE 76. LAMEA ATRIAL FIBRILLATION MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 77. LAMEA ATRIAL FIBRILLATION MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 78. LATIN AMERICA ATRIAL FIBRILLATION MARKET BY TYPE 2020-2030,($MILLION)
TABLE 79. LATIN AMERICA ATRIAL FIBRILLATION MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 80. LATIN AMERICA ATRIAL FIBRILLATION MARKET BY END USER 2020-2030,($MILLION)
TABLE 81. MIDDLE EAST ATRIAL FIBRILLATION MARKET BY TYPE 2020-2030,($MILLION)
TABLE 82. MIDDLE EAST ATRIAL FIBRILLATION MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 83. MIDDLE EAST ATRIAL FIBRILLATION MARKET BY END USER 2020-2030,($MILLION)
TABLE 84. AFRICA ATRIAL FIBRILLATION MARKET BY TYPE 2020-2030,($MILLION)
TABLE 85. AFRICA ATRIAL FIBRILLATION MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 86. AFRICA ATRIAL FIBRILLATION MARKET BY END USER 2020-2030,($MILLION)
TABLE 87.JOHNSON & JOHNSON: COMPANY SNAPSHOT
TABLE 88.JOHNSON & JOHNSON: OPERATING SEGMENTS
TABLE 89.JOHNSON & JOHNSON: PRODUCT PORTFOLIO
TABLE 90.JOHNSON & JOHNSON: NET SALES,
TABLE 91.JOHNSON & JOHNSON: KEY STRATERGIES
TABLE 92.MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
TABLE 93.MICROPORT SCIENTIFIC CORPORATION: OPERATING SEGMENTS
TABLE 94.MICROPORT SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
TABLE 95.MICROPORT SCIENTIFIC CORPORATION: NET SALES,
TABLE 96.MICROPORT SCIENTIFIC CORPORATION: KEY STRATERGIES
TABLE 97.BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
TABLE 98.BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS
TABLE 99.BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
TABLE 100.BOSTON SCIENTIFIC CORPORATION: NET SALES,
TABLE 101.BOSTON SCIENTIFIC CORPORATION: KEY STRATERGIES
TABLE 102.ST. JUDE MEDICAL: COMPANY SNAPSHOT
TABLE 103.ST. JUDE MEDICAL: OPERATING SEGMENTS
TABLE 104.ST. JUDE MEDICAL: PRODUCT PORTFOLIO
TABLE 105.ST. JUDE MEDICAL: NET SALES,
TABLE 106.ST. JUDE MEDICAL: KEY STRATERGIES
TABLE 107.MEDTRONIC PLC: COMPANY SNAPSHOT
TABLE 108.MEDTRONIC PLC: OPERATING SEGMENTS
TABLE 109.MEDTRONIC PLC: PRODUCT PORTFOLIO
TABLE 110.MEDTRONIC PLC: NET SALES,
TABLE 111.MEDTRONIC PLC: KEY STRATERGIES
TABLE 112.ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 113.ABBOTT LABORATORIES: OPERATING SEGMENTS
TABLE 114.ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 115.ABBOTT LABORATORIES: NET SALES,
TABLE 116.ABBOTT LABORATORIES: KEY STRATERGIES
TABLE 117.BIOTRONIK SE & CO. KG: COMPANY SNAPSHOT
TABLE 118.BIOTRONIK SE & CO. KG: OPERATING SEGMENTS
TABLE 119.BIOTRONIK SE & CO. KG: PRODUCT PORTFOLIO
TABLE 120.BIOTRONIK SE & CO. KG: NET SALES,
TABLE 121.BIOTRONIK SE & CO. KG: KEY STRATERGIES
TABLE 122.KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
TABLE 123.KONINKLIJKE PHILIPS N.V.: OPERATING SEGMENTS
TABLE 124.KONINKLIJKE PHILIPS N.V.: PRODUCT PORTFOLIO
TABLE 125.KONINKLIJKE PHILIPS N.V.: NET SALES,
TABLE 126.KONINKLIJKE PHILIPS N.V.: KEY STRATERGIES
TABLE 127.SIEMENS AG: COMPANY SNAPSHOT
TABLE 128.SIEMENS AG: OPERATING SEGMENTS
TABLE 129.SIEMENS AG: PRODUCT PORTFOLIO
TABLE 130.SIEMENS AG: NET SALES,
TABLE 131.SIEMENS AG: KEY STRATERGIES
TABLE 132.ATRICURE INC: COMPANY SNAPSHOT
TABLE 133.ATRICURE INC: OPERATING SEGMENTS
TABLE 134.ATRICURE INC: PRODUCT PORTFOLIO
TABLE 135.ATRICURE INC: NET SALES,
TABLE 136.ATRICURE INC: KEY STRATERGIES

LIST OF FIGURES
FIGURE 1.ATRIAL FIBRILLATION MARKET SEGMENTATION
FIGURE 2.ATRIAL FIBRILLATION MARKET,2020-2030
FIGURE 3.ATRIAL FIBRILLATION MARKET,2020-2030
FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
FIGURE 5.PORTER FIVE-1
FIGURE 6.PORTER FIVE-2
FIGURE 7.PORTER FIVE-3
FIGURE 8.PORTER FIVE-4
FIGURE 9.PORTER FIVE-5
FIGURE 10.TOP PLAYER POSITIONING
FIGURE 11.ATRIAL FIBRILLATION MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 11.ATRIAL FIBRILLATION MARKET,BY TYPE,2020(%)
FIGURE 12.COMPARATIVE SHARE ANALYSIS OF SURGICAL ATRIAL FIBRILLATION MARKET,2020-2030(%)
FIGURE 13.COMPARATIVE SHARE ANALYSIS OF NON-SURGICAL ATRIAL FIBRILLATION MARKET,2020-2030(%)
FIGURE 14.ATRIAL FIBRILLATION MARKET,BY TECHNOLOGY,2020(%)
FIGURE 15.COMPARATIVE SHARE ANALYSIS OF RADIOFREQUENCY ATRIAL FIBRILLATION MARKET,2020-2030(%)
FIGURE 16.COMPARATIVE SHARE ANALYSIS OF LASER ATRIAL FIBRILLATION MARKET,2020-2030(%)
FIGURE 17.COMPARATIVE SHARE ANALYSIS OF CRYOTHERAPY ATRIAL FIBRILLATION MARKET,2020-2030(%)
FIGURE 18.COMPARATIVE SHARE ANALYSIS OF OTHERS ATRIAL FIBRILLATION MARKET,2020-2030(%)
FIGURE 19.ATRIAL FIBRILLATION MARKET,BY END USER,2020(%)
FIGURE 20.COMPARATIVE SHARE ANALYSIS OF HOSPITALS ATRIAL FIBRILLATION MARKET,2020-2030(%)
FIGURE 21.COMPARATIVE SHARE ANALYSIS OF SPECIALTY CLINICS ATRIAL FIBRILLATION MARKET,2020-2030(%)
FIGURE 22.COMPARATIVE SHARE ANALYSIS OF OTHERS ATRIAL FIBRILLATION MARKET,2020-2030(%)
FIGURE 23.ATRIAL FIBRILLATION MARKET BY REGION,2020
FIGURE 24.U.S. ATRIAL FIBRILLATION MARKET,2020-2030($MILLION)
FIGURE 25.CANADA ATRIAL FIBRILLATION MARKET,2020-2030($MILLION)
FIGURE 26.MEXICO ATRIAL FIBRILLATION MARKET,2020-2030($MILLION)
FIGURE 27.GERMANY ATRIAL FIBRILLATION MARKET,2020-2030($MILLION)
FIGURE 28.FRANCE ATRIAL FIBRILLATION MARKET,2020-2030($MILLION)
FIGURE 29.U.K. ATRIAL FIBRILLATION MARKET,2020-2030($MILLION)
FIGURE 30.ITALY ATRIAL FIBRILLATION MARKET,2020-2030($MILLION)
FIGURE 31.REST OF EUROPE ATRIAL FIBRILLATION MARKET,2020-2030($MILLION)
FIGURE 32.CHINA ATRIAL FIBRILLATION MARKET,2020-2030($MILLION)
FIGURE 33.INDIA ATRIAL FIBRILLATION MARKET,2020-2030($MILLION)
FIGURE 34.JAPAN ATRIAL FIBRILLATION MARKET,2020-2030($MILLION)
FIGURE 35.SOUTH KOREA ATRIAL FIBRILLATION MARKET,2020-2030($MILLION)
FIGURE 36.REST OF ASIA-PACIFIC ATRIAL FIBRILLATION MARKET,2020-2030($MILLION)
FIGURE 37.LATIN AMERICA ATRIAL FIBRILLATION MARKET,2020-2030($MILLION)
FIGURE 38.MIDDLE EAST ATRIAL FIBRILLATION MARKET,2020-2030($MILLION)
FIGURE 39.AFRICA ATRIAL FIBRILLATION MARKET,2020-2030($MILLION)
FIGURE 40. TOP WINNING STRATEGIES, BY YEAR
FIGURE 41. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 42. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 43.PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 44.COMPETITIVE DASHBOARD
FIGURE 45.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
FIGURE 46.JOHNSON & JOHNSON.: NET SALES ,($MILLION)
FIGURE 47.MICROPORT SCIENTIFIC CORPORATION.: NET SALES ,($MILLION)
FIGURE 48.BOSTON SCIENTIFIC CORPORATION.: NET SALES ,($MILLION)
FIGURE 49.ST. JUDE MEDICAL.: NET SALES ,($MILLION)
FIGURE 50.MEDTRONIC PLC.: NET SALES ,($MILLION)
FIGURE 51.ABBOTT LABORATORIES.: NET SALES ,($MILLION)
FIGURE 52.BIOTRONIK SE & CO. KG.: NET SALES ,($MILLION)
FIGURE 53.KONINKLIJKE PHILIPS N.V..: NET SALES ,($MILLION)
FIGURE 54.SIEMENS AG.: NET SALES ,($MILLION)
FIGURE 55.ATRICURE INC.: NET SALES ,($MILLION)

ページTOPに戻る

Table of Contents

Summary

The atrial fibrillation market size was valued at $1,825.8 million in 2020, and is projected to reach $3,370.7 million by 2030, registering a CAGR of 6.4% from 2021 to 2030. Atrioventricular fibrillation (AFib) is a disorder, in which the heart's upper chambers (atria) beat quickly and erratically (fibrillate). Blood can accumulate and clot in the left atrial appendage of the heart as a result of AFib. A stroke can occur when a blood-clot escapes from the left atrial appendage (LAA) and transfers to another parts or organs of the body. Atrial fibrillation can increase the risk of heart stroke, induce chest discomfort, or even trigger a heart attack, especially if the heart beat is extremely rapid, and can produce blood clots in the heart that spread to other organs.
The global atrial fibrillation market is expanding along with the increase in the ageing population. In addition, high blood pressure, obesity, and diabetes result in the increase in occurrence of atrial fibrillation in the geriatric population. According to the Centers for Disease Control and Prevention (CDC) estimates of the prevalence of AFib in the U.S. ranges from about 2.7 million to 6.1 million. That number is estimated to rise to 12.1 million in 2030. Such factors are expected to increase the demand for atrial fibrillation devices during the forecast period. Furthermore, technical advancements in surgical devices for atrial fibrillation propel the atrial fibrillation market forward. However, problems such as expensive atrial fibrillation treatment costs and costly medical devices are expected to hamper the market expansion.
Moreover, technological advancements force key players to introduce atrial fibrillation monitoring and devices in the medical and pharmaceutical sectors. For instance, in February 2020, Janssen Pharmaceutical Companies of Johnson & Johnson collaborated with Apple Inc. and introduced Heartline Monitor. It improves health outcomes, such as lowering the risk of stroke, by detecting atrial fibrillation (AFib) earlier.
The market is segmented on the basis of type, technology, end user and geography. On the basis of type, it is divided into surgical and non-surgical. On the basis of technology, it is divided into radiofrequency, laser, cryotherapy, and others. On the basis of end user, the market is segmented into hospitals, specialty clinics, and others. Region-wise, the market analysis is conducted across North America (the U.S., Canada, and Mexico), Europe (the UK, France, Germany, Italy, and Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, and Rest of Asia-Pacific), and LAMEA (Latin America, the Middle East, and Africa).

Competition Analysis
The key players operating in the global atrial fibrillation market are Abbott Laboratories, Johnson & Johnson, MicroPort Scientific Corporation, Boston Scientific Corporation, Medtronic plc, Biotronik SE & Co. KG, Philips N.V., Siemens AG, AtriCure Inc., and CardioFocus, Inc.

Key Benefits For Stakeholders
The report provides an extensive analysis of the current and emerging atrial fibrillation market trends and dynamics.
In-depth atrial fibrillation market analysis is conducted by constructing market estimations for key market segments between 2021 and 2030.
Extensive analysis of the atrial fibrillation market is conducted by following key product positioning and monitoring of top competitors within the market framework.
A comprehensive analysis of all the regions is provided to determine the prevailing opportunities.
The global atrial fibrillation market forecast analysis from 2021 to 2030 is included in the report.
The key players within atrial fibrillation market are profiled in this report and their strategies are analyzed thoroughly, which help understand the competitive outlook of the atrial fibrillation industry.

Global Atrial Fibrillation Market Segments

# BY TYPE
## Surgical
## Non-surgical

# BY TECHNOLOGY
## Radiofrequency
## Laser
## Cryotherapy
## Others

# BY END USER
## Hospitals
## Specialty Clinics
## Others

# BY REGION
## North America
### U.S.
### Canada
### Mexico
## Europe
### Germany
### UK
### France
### Italy
### Rest of Europe

## Asia-Pacific
### China
### India
### Japan
### South Korea
### Rest of Asia-Pacific

## LAMEA
### Latin America
### Middle East
### Africa

KEY PLAYERS
Abbott Laboratories
Johnson & Johnson
MicroPort Scientific Corporation
Boston Scientific Corporation
Medtronic plc
Biotronik SE & Co. KG
Philips N.V.
Siemens AG
AtriCure Inc.
CardioFocus, Inc.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医療/ヘルスケア）の最新刊レポート

Allied Market Research社のその他分野での最新刊レポート

本レポートと同じKEY WORD（atrial fibrillation）の最新刊レポート

よくあるご質問

Allied Market Research社はどのような調査会社ですか?

アライドマーケットリサーチ（Allied Market Research）は世界の多様な市場に関する戦略や将来推計、成長/衰退予測、機会分析、消費者調査などを行い、市場調査レポートを積極的に出版しています。もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

心房細動市場：タイプ別（外科手術、非外科手術）、技術別（高周波、レーザー、凍結療法、その他）、エンドユーザー別（病院、専門診療所、その他）。世界の機会分析および産業予測、2020-2030年

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（医療/ヘルスケア）の最新刊レポート

Allied Market Research社のその他分野での最新刊レポート

本レポートと同じKEY WORD（atrial fibrillation）の最新刊レポート

よくあるご質問

Allied Market Research社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?